| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.8M | +13.7% |
| SG&A Expense | $6.3M | -40.8% |
| Operating Income | -$12.1M | +23.0% |
| Net Income | -$12.1M | +20.6% |
| EPS (Basic) | -$2.84 | +78.1% |
| EPS (Diluted) | -$2.84 | +78.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.6M | -83.8% |
| Total Assets | $1.6M | -83.8% |
| Current Liabilities | $2.5M | -67.9% |
| Total Liabilities | $2.5M | -67.9% |
| Stockholders' Equity | -$914K | -147.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.7M | -69.6% |
| Financing Cash Flow | $9.1M | — |